Reinhard Tober

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index526citations19works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(14), Virology and Viral Diseases(6), Animal Virus Infections Studies(5), Veterinary Oncology Research(4), Immunotherapy and Immune Responses(3)

Publications19 total

Data from Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
2023Open Access
Supplementary Figures 1 - 7 from Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
2023Open Access
Data from Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
2023Open Access
Supplementary Figures 1 - 7 from Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
2023Open Access
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
Viruses·2018· 68 citedOpen Access
Abstract B37: VSV-GP: A vaccine vector and oncolytic virus
Cancer Immunology Research·2015
The Viral Vector Vaccine VSV-GP Boosts the Immune Response upon Repeated Applications
AIDS Research and Human Retroviruses·2014
824: Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity and enhance oncolytic potency
European Journal of Cancer·2014· 3 cited
Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
Cancer Research·2014· 134 cited
VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications
Journal of Virology·2014· 66 citedOpen Access
Vesicular Stomatitis Virus pseudotyped with the glycoprotein of the Lymphocytic Choriomeningitis Virus (VSV-GP) as a novel vaccine vector platform / by Reinhard Tober
2014
The viral vector vaccine VSV-GP boosts immune response upon repeated applications
Retrovirology·2012Open Access
Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation
Journal of General Virology·2011· 45 citedOpen Access
Bovine papillomavirus <i>type 1</i> and <i>Equus caballus</i> papillomavirus 2 in equine squamous cell carcinoma of the head and neck in a Connemara mare
Equine Veterinary Journal·2011· 42 cited
BPV-1 infection is not confined to the dermis but also involves the epidermis of equine sarcoids
Veterinary Microbiology·2010· 52 cited
Prevalence of bovine papillomavirus and Treponema DNA in bovine digital dermatitis lesions
Veterinary Microbiology·2010· 46 cited
Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker
Equine Veterinary Journal·2010· 43 cited
Identification of two GH18 chitinase family genes and their use as targets for detection of the crayfish-plague oomycete Aphanomyces astaci
BMC Microbiology·2009· 27 citedOpen Access
Entwurf für ein ISO - Prüfverfahren eines manuell stabilisierten Treppensteigers
reposiTUm (TU Wien)·2009Open Access

Frequent Co-authors

Dorotheé von Laer(11), Alexander Muik(10), Janine Kimpel(10), Lawton J. Stubbert(6), Roza Z. Jahedi(6), Ursula Dietrich(6), Hrvoje Miletić(6), John C. Bell(6), Yvonne Geiβ(5), Catherine Dold(5), Andreas Volk(5), Sabine Klein(5), Beta Yadollahi(5), Theresa Falls(5), David F. Stojdl(5), Sabine Brandt(5), Christina Kainzbauer(5), Zoltán Bánki(4), Lisa Egerer(3), Ralf Steinborn(3)